Your browser doesn't support javascript.
loading
No, it is not mutually exclusive! A case report of a girl with two genetic diagnoses: Craniofrontonasal dysplasia and pontocerebellar hypoplasia type 1B.
Ibrahim, Iman; Scriver, Tara; Basalom, Shuaa A.
Affiliation
  • Ibrahim I; School of Health Studies, Elborn College Western University London Ontario Canada.
  • Scriver T; Division of Medical Genetics, Department of Pediatrics, Royal University Hospital University of Saskatchewan Saskatoon Saskatchewan Canada.
  • Basalom SA; Division of Medical Genetics, Department of Pediatrics, Royal University Hospital University of Saskatchewan Saskatoon Saskatchewan Canada.
Clin Case Rep ; 11(5): e7332, 2023 May.
Article in En | MEDLINE | ID: mdl-37180334
ABSTRACT
Key Clinical Message Multiple genetic disorders can coexist in one patient. When the phenotype is not fully explained with one diagnosis, it is recommended to perform further genetic investigations in search for coexisting second diagnosis. Abstract Craniofrontonasal dysplasia (CFND) (MIM 304110) is an X-linked dominant disorder that shows paradoxically greater severity in heterozygous females than in hemizygous males. It is caused by a pathogenic variant in EFNB1. Pontocerebellar hypoplasia type 1B (PCH1B) (MIM 614678) is an extremely rare condition with over 100 individuals reported to date. It is caused by biallelic pathogenic variants in EXOSC3. This report presents the case of a girl who was diagnosed prenatally with CFND based on the findings on the prenatal imaging and the known diagnosis of CFND in her mother. She has severe global development delay that cannot be explained solely by the CFND diagnosis. Around the age of 2 years, she was diagnosed with PCH1B following whole exome sequencing (WES) testing. The objective of this study is to highlight the importance of pursuing genetic investigation if the available genetic diagnosis cannot fully explain the clinical picture. This is a case report of one patient and review of the literature. Informed consent was obtained from the parents. WES was performed by a private lab using next-generation sequencing (NGS), DNA was sequenced on the NovaSeq 6000 using 2 × 150 bp paired-end read. WES identified the following homozygous pathogenic variant in EXOSC3 C.395A>C, p.ASp132Ala, maternally inherited, likely pathogenic duplication at Xq13.1 (includes EFNB1) and paternally inherited 16p11.2 duplication that is classified as a variant of uncertain significance. Perusing more extensive genetic testing like WES is indicated if the current genetic diagnosis cannot fully explain the phenotype in a patient.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Clin Case Rep Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Clin Case Rep Year: 2023 Document type: Article